Amgen Appoints Harvard Business Professor to Board

Biotechnology company Amgen Inc. said Friday that Rebecca Henderson has been appointed to the board of directors.

Henderson, 48, recently became a professor at Harvard Business School and has been a director at IDEXX Laboratories Inc. since 2003. Amgen said her specialties include technology strategy and strategic problems faced by companies in high technology industries. She is also a research associate at the National Bureau of Economic Research.

Her appointment expands the size of Amgen's board to 13.

Amgen shares lost 32 cents to close at $57.81 Friday.

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.